Mantle Cell Lymphoma Video Channel
Explore the latest insights and summaries from experts in Mantle Cell Lymphoma.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Management of MCL
FEATURING
Andre Goy
- 131 views
- March 27, 2024
- 3
University of Miami Sylvester Comprehensive Cancer Center
Using BTKis in MCL Today
FEATURING
Alvaro Alencar
- 66 views
- May 7, 2024
Rush University Medical Center
Optimal Timing of CAR T-Cell Therapies in MCL: Cellular Therapy and Beyond
FEATURING
Sunita Nathan
- 18 views
- June 13, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
FEATURING
Wojciech Jurczak
- 39 views
- June 30, 2024
SOHO Brazil 2024
Making Sense of 1L Treatment Options in MCL
FEATURING
Tycel Phillips
- 120 views
- July 11, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Updates on Mantle Cell Lymphoma
FEATURING
Elif Ateşoğlu
- 32 views
- September 27, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in the Treatment of MCL
FEATURING
Georg Hess
- 251 views
- September 27, 2024
Oncology Data Advisor
Lymphoma Awareness Month: Nursing and Patient Advocacy Perspectives
FEATURING
Maria Badillo,
Lauren Ghazal
- November 26, 2024
Therapeutic Agents
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: Management of MCL
FEATURING
Andre Goy
- 131 views
- March 27, 2024
- 3
University of Miami Sylvester Comprehensive Cancer Center
Using BTKis in MCL Today
FEATURING
Alvaro Alencar
- 66 views
- May 7, 2024
University of Miami Sylvester Comprehensive Cancer Center
Evaluating Zanubrutinib + Tafasitamab in MCL
FEATURING
Alvaro Alencar
- 26 views
- May 7, 2024
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: SYMPATICO Study - Ibrutinib + Venetoclax in MCL With TP53 Mutations
FEATURING
Wojciech Jurczak
- 39 views
- June 30, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Benefit of R Maintenance After 1L BR in MCL"
FEATURING
Yucai Wang
- 70 views
- July 11, 2024
- 1
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Sonrotoclax and Zanubrutinib Combination Therapy for R/R MCL
FEATURING
Constantine Tam
- 24 views
- July 18, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in the Treatment of MCL
FEATURING
Georg Hess
- 251 views
- September 27, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Acalabrutinib, Venetoclax, and Obinutuzumab in Patients With MCL - MAVO Phase 1/2 Study
FEATURING
Austin Kim
- 16 views
- December 13, 2024
Diagnostics & Biomarkers
No available content for Diagnostics & Biomarkers, yet.
Disease Overview
No available content for Disease Overview, yet.
Case Studies
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Case Discussion: Managment of High-Risk MCL
FEATURING
Ahmet Mert Yanık
- 27 views
- August 15, 2024